The Secret to Facial Rejuvenation

Model is not an actual patient.

Discover why Ellansé is the Secret to
Facial Rejuvenation

How ELLANSÉ is different

Collagen is a powerful, natural protein that exists within all of us.

But did you know that your levels of collagen can start to decrease as early as in your twenties? The good news is that you can take back control. With the help of Ellansé, you can reboot your body’s natural collagen production.
01 Copy
Model is not an actual patient.

Rebuilding your natural beauty.

Where others’ benefits end at correcting lines and folds, Ellansé goes beyond, goes deeper, working to treat the true causes of facial ageing.
11
Model is not an actual patient.

Instant volume, long-lasting benefits.

While it instantly addresses lines and wrinkles, it also uses your body’s natural processes to set in motion long-term collagen production, safely restoring volume, rejuvenating your appearance from within.
02
Model is not an actual patient.

Restoring youth and enhancing form

${ item.title }

${ item.title }

${ item.text }> ${ item.cta.name }
Model is not an actual patient.
I have been using Ellansé for 8 years and performed many treatments during this time: I love seeing the benefits of working with such a versatile product.
Dr. Shang-Li Lin

Find your clinic

Search your location or postcode to find a physician near you

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Pharma Corporate Safety Group: quality@sinclairpharma.com